The small-for-size syndrome in living donor liver transplantation: current management - Takeaways - MDSpire

The small-for-size syndrome in living donor liver transplantation: current management

  • By

  • Luca Del Prete

  • Cristiano Quintini

  • Teresa Diago Uso

  • October 29, 2024

  • 0 min

Share

  • 1

    Small-for-size syndrome (SFSS) in living donor liver transplantation is linked to a graft-to-recipient weight ratio of less than 1%.

  • 2

    SFSS manifests as hyperbilirubinemia, impaired liver function, and can lead to severe complications like liver failure and sepsis.

  • 3

    Risk factors for SFSS include graft size, donor age over 45, high BMI, graft steatosis, and recipient disease severity.

  • 4

    Hemodynamic monitoring during transplantation is crucial to prevent SFSS by ensuring adequate portal vein and hepatic artery flow.

  • 5

    Correct donor-recipient matching and management of graft inflow can help predict and prevent the occurrence of SFSS.

Original Source(s)

The small-for-size syndrome in living donor liver transplantation: current management

  • by Luca Del Prete, Cristiano Quintini, Teresa Diago Uso

  • October 29, 2024

Related Content

Infectious complications after transrectal MRI-targeted and systematic prostate biopsy

Leukemia Case Prompts Broader Review

Researchers assess hematologic malignancies temporally associated with mRNA COVID-19 vaccination.

A Case Study of Severe Sepsis Due to Methicillin-Resistant Staphylococcus aureus (MRSA) with Pulmonary Abscesses and Humeral Osteomyelitis in a Previously Healthy Pediatric Patient